Compare Host Hotels & Resorts Inc. Common Stock (HST) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Host Hotels & Resorts Inc. Common Stock vs Natera Inc. Common Stock — how do they compare? Host Hotels & Resorts Inc. Common Stock trades at $23.1 (market cap $15.71B), while Natera Inc. Common Stock trades at $393.93 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 3.6× Host Hotels & Resorts Inc. Common Stock's market cap, and Host Hotels & Resorts Inc. Common Stock pays a 3.49% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Host Hotels & Resorts Inc. Common Stock for 5 Days and Natera Inc. Common Stock for 0 Days on average.
| HST | NTRA | |
|---|---|---|
Market Cap | $15.71B | $57.03B |
Volume | 9,244,414 | 1,131,157 |
Sector | Real Estate | Health |
52-Week High | $25.54 | $425.64 |
52-Week Low | $16.02 | $179.42 |
Typical Hold Time | 5 Days | 0 Days |
Enterprise Value | $19.40B | $56.18B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Host Hotels & Resorts (HST) trades at $23.22, up 2.11% on the day, reflecting strong momentum. The stock shows a bullish technical signal with moving averages supporting an uptrend. Fundamentally, the company reported robust earnings, beating estimates in recent quarters, with Q1 2026 EPS of $0.67 significantly exceeding expectations. Revenue for 2025 reached $6.11 billion, and net income margin improved to 16.51% in 2026. Analyst sentiment is positive, with a consensus price target of $25.53, indicating potential upside from current levels.
The outlook for HST is favorable, driven by earnings growth and a solid balance sheet, but risks include economic sensitivity to travel demand and dividend sustainability during downturns. Investment opportunity lies in continued operational strength and valuation appeal, with a P/E of 15.58 below industry averages. Investors should monitor travel sector volatility and interest rate impacts on hotel financing.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Host Hotels & Resorts Inc. Common Stock
Host Hotels & Resorts is a real estate investment trust that owns luxury and upscale hotel properties. Its portfolio includes hotels operated under major global brands.
Read more on HST →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
